Wellington Shields Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,103
| Closed | -$127K | – | 315 |
|
|
2024
Q3 | $127K | Hold |
3,103
| – | – | 0.02% | 263 |
|
|
2024
Q2 | $119K | Buy |
3,103
+1
| +0% | +$38 | 0.02% | 259 |
|
|
2024
Q1 | $133K | Buy |
3,102
+1
| +0% | +$43 | 0.03% | 252 |
|
|
2023
Q4 | $115K | Buy |
3,101
+1
| +0% | +$37 | 0.01% | 254 |
|
|
2023
Q3 | $112K | Sell |
3,100
-400
| -11% | -$14.5K | 0.01% | 254 |
|
|
2023
Q2 | $125K | Hold |
3,500
| – | – | 0.02% | 242 |
|
|
2023
Q1 | $125K | Hold |
3,500
| – | – | 0.02% | 250 |
|
|
2022
Q4 | $123K | Hold |
3,500
| – | – | 0.01% | 249 |
|
|
2022
Q3 | $103K | Buy |
3,500
+3,260
| +1,358% | +$95.9K | 0.02% | 252 |
|
|
2022
Q2 | $13K | Hold |
240
| – | – | ﹤0.01% | 293 |
|
|
2022
Q1 | $13K | Buy |
+240
| New | +$13K | ﹤0.01% | 309 |
|
|
2018
Q1 | – | Sell |
-6,320
| Closed | -$280K | – | 335 |
|
|
2017
Q4 | $280K | Sell |
6,320
-800
| -11% | -$35.4K | 0.04% | 286 |
|
|
2017
Q3 | $361K | Hold |
7,120
| – | – | 0.06% | 239 |
|
|
2017
Q2 | $384K | Sell |
7,120
-560
| -7% | -$30.2K | 0.06% | 241 |
|
|
2017
Q1 | $405K | Sell |
7,680
-160
| -2% | -$8.44K | 0.07% | 222 |
|
|
2016
Q4 | $377K | Sell |
7,840
-400
| -5% | -$19.2K | 0.06% | 229 |
|
|
2016
Q3 | $444K | Buy |
8,240
+880
| +12% | +$47.4K | 0.08% | 222 |
|
|
2016
Q2 | $399K | Buy |
7,360
+1,520
| +26% | +$82.4K | 0.07% | 229 |
|
|
2016
Q1 | $296K | Buy |
5,840
+1,360
| +30% | +$68.9K | 0.05% | 257 |
|
|
2015
Q4 | $226K | Buy |
+4,480
| New | +$226K | 0.04% | 276 |
|